Fibrocell Science (FCSC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2003 | 12-2002 | 12-2001 | 12-2000 | |
| Cash Flows From Operating Activities | ||||
| Net Income | -11,268 | -5,433 | -1,652 | -807 |
| Depreciation Amortization | 835 | 100 | 15 | 16 |
| Accounts receivable | -167 | -39 | 1 | 11 |
| Accounts payable and accrued liabilities | -421 | 1,673 | 60 | -1 |
| Other Working Capital | 117 | 808 | 20 | 530 |
| Other Operating Activity | 1,607 | -1,076 | 892 | -10 |
| Operating Cash Flow | $-9,297 | $-3,968 | $-664 | $-260 |
| Cash Flows From Investing Activities | ||||
| PPE Investments | -1,160 | -2,252 | 1 | N/A |
| Investing Cash Flow | $-1,160 | $-2,252 | $1 | $N/A |
| Cash Flows From Financing Activities | ||||
| Debt Issued | N/A | N/A | 30 | 200 |
| Common Stock Issued | 19,138 | 58 | 2,060 | 2 |
| Dividend Paid | -1,087 | N/A | N/A | N/A |
| Other Financing Activity | 3,881 | 9,013 | -49 | 0 |
| Financing Cash Flow | $21,931 | $9,070 | $2,042 | $202 |
| Exchange Rate Effect | 217 | 14 | N/A | N/A |
| Beginning Cash Position | 4,245 | 1,381 | 3 | 61 |
| End Cash Position | 15,936 | 4,245 | 1,381 | 3 |
| Net Cash Flow | $11,691 | $2,864 | $1,378 | $-58 |
| Free Cash Flow | ||||
| Operating Cash Flow | -9,297 | -3,968 | -664 | -260 |
| Capital Expenditure | -1,193 | -2,252 | N/A | N/A |
| Free Cash Flow | -10,490 | -6,220 | -664 | -260 |